{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:32:51Z","timestamp":1784759571633,"version":"3.55.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.isci.2025.112625","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T08:12:07Z","timestamp":1746778327000},"page":"112625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Promoting vascular stability through Src inhibition and Tie2 activation: A model-based analysis"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3643-6589","authenticated-orcid":false,"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Kontos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H.","family":"Annex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander S.","family":"Popel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.112625_bib1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41573-023-00671-z","article-title":"Targeting angiogenesis in oncology, ophthalmology and beyond","volume":"22","author":"Cao","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2025.112625_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10456-023-09876-7","article-title":"Pathological angiogenesis: mechanisms and therapeutic strategies","volume":"26","author":"Dudley","year":"2023","journal-title":"Angiogenesis"},{"key":"10.1016\/j.isci.2025.112625_bib3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nrclinonc.2018.9","article-title":"Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa","volume":"15","author":"Khan","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2025.112625_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12964-022-00838-y","article-title":"Cancer combination therapies by angiogenesis inhibitors; a comprehensive review","volume":"20","author":"Ansari","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.isci.2025.112625_bib5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/eye.2015.110","article-title":"A review of therapies for diabetic macular oedema and rationale for combination therapy","volume":"29","author":"Amoaku","year":"2015","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.isci.2025.112625_bib6","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1161\/CIRCRESAHA.121.318266","article-title":"New Directions in Therapeutic Angiogenesis and Arteriogenesis in Peripheral Arterial Disease","volume":"128","author":"Annex","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.isci.2025.112625_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jacbts.2017.07.012","article-title":"Therapeutic Angiogenesis for Peripheral Artery Disease: Lessons Learned in Translational Science","volume":"2","author":"Iyer","year":"2017","journal-title":"JACC. Basic Transl. Sci."},{"key":"10.1016\/j.isci.2025.112625_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrcardio.2013.70","article-title":"Therapeutic angiogenesis for critical limb ischaemia","volume":"10","author":"Annex","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.isci.2025.112625_bib9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.112625_bib10","article-title":"Systems biology of angiogenesis signaling: Computational models and omics","volume":"14","author":"Zhang","year":"2022","journal-title":"WIREs Mech. Dis."},{"key":"10.1016\/j.isci.2025.112625_bib11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ceb.2010.08.010","article-title":"Dynamics of endothelial cell behavior in sprouting angiogenesis","volume":"22","author":"Eilken","year":"2010","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.isci.2025.112625_bib12","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in Signaling and Disease: Beyond Discovery and Development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.112625_bib13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/10739680802095964","article-title":"Systems biology of vascular endothelial growth factors","volume":"15","author":"Mac Gabhann","year":"2008","journal-title":"Microcirculation"},{"key":"10.1016\/j.isci.2025.112625_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/gb-2005-6-2-209","article-title":"The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease","volume":"6","author":"Holmes","year":"2005","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2025.112625_bib15","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03720","article-title":"Neuropilin-1 functions as a VEGFR2 co-receptor to guide developmental angiogenesis independent of ligand binding","volume":"3","author":"Gelfand","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.isci.2025.112625_bib16","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/ncomms1977","article-title":"The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis","volume":"3","author":"Cudmore","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112625_bib17","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.4049\/jimmunol.1303116","article-title":"CD47 signaling regulates the immunosuppressive activity of VEGF in T cells","volume":"193","author":"Kaur","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2025.112625_bib18","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/emboj.2012.21","article-title":"Axl is essential for VEGF-A-dependent activation of PI3K\/Akt","volume":"31","author":"Ruan","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.isci.2025.112625_bib19","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.4161\/cc.20535","article-title":"VEGF-A engages at least three tyrosine kinases to activate PI3K\/Akt","volume":"11","author":"Ruan","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.isci.2025.112625_bib20","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1093\/emboj\/cdg540","article-title":"Activation of sphingosine kinase 1 by ERK1\/2-mediated phosphorylation","volume":"22","author":"Pitson","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.isci.2025.112625_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cbi.2007.08.006","article-title":"Regulation of endothelial permeability by Src kinase signaling: vascular leakage versus transcellular transport of drugs and macromolecules","volume":"171","author":"Hu","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.isci.2025.112625_bib22","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.yexcr.2013.03.011","article-title":"Angiopoietin signaling in the vasculature","volume":"319","author":"Eklund","year":"2013","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.isci.2025.112625_bib23","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006650","article-title":"The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway","volume":"2","author":"Thurston","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.isci.2025.112625_bib24","doi-asserted-by":"crossref","first-page":"20126","DOI":"10.1074\/jbc.M500292200","article-title":"Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2","volume":"280","author":"Kim","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.112625_bib25","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1172\/JCI74527","article-title":"Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature","volume":"124","author":"Shen","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2025.112625_bib26","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1073\/pnas.1616166114","article-title":"Structural basis of Tie2 activation and Tie2\/Tie1 heterodimerization","volume":"114","author":"Leppanen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112625_bib27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.molcel.2010.02.007","article-title":"Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands","volume":"37","author":"Seegar","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2025.112625_bib28","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1172\/JCI89963","article-title":"Tie1: an orphan receptor provides context for angiopoietin-2\/Tie2 signaling","volume":"126","author":"Mueller","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2025.112625_bib29","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.celrep.2015.08.024","article-title":"The Orphan Receptor Tie1 Controls Angiogenesis and Vascular Remodeling by Differentially Regulating Tie2 in Tip and Stalk Cells","volume":"12","author":"Savant","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2025.112625_bib30","article-title":"The molecular balance between receptor tyrosine kinases Tie1 and Tie2 is dynamically controlled by VEGF and TNFalpha and regulates angiopoietin signalling","volume":"7","author":"Singh","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.112625_bib31","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/ATVBAHA.107.150482","article-title":"VEGF induces Tie2 shedding via a phosphoinositide 3-kinase\/Akt dependent pathway to modulate Tie2 signaling","volume":"27","author":"Findley","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.isci.2025.112625_bib32","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ncb1714","article-title":"Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1","volume":"10","author":"Fukuhara","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.isci.2025.112625_bib33","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ncb1715","article-title":"Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts","volume":"10","author":"Saharinen","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.isci.2025.112625_bib34","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1182\/blood-2003-03-0670","article-title":"Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1","volume":"102","author":"Cascone","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.isci.2025.112625_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.devcel.2007.10.019","article-title":"Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia","volume":"14","author":"Gavard","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.isci.2025.112625_bib36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/ATVBAHA.108.172676","article-title":"Angiopoietin-2 exocytosis is stimulated by sphingosine-1-phosphate in human blood and lymphatic endothelial cells","volume":"29","author":"Jang","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.isci.2025.112625_bib37","doi-asserted-by":"crossref","first-page":"10664","DOI":"10.1073\/pnas.1934494100","article-title":"VEGF induces S1P1 receptors in endothelial cells: Implications for cross-talk between sphingolipid and growth factor receptors","volume":"100","author":"Igarashi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112625_bib38","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1006\/excr.1999.4693","article-title":"Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells","volume":"253","author":"Fujikawa","year":"1999","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.isci.2025.112625_bib39","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41433-020-01377-x","article-title":"Angiopoietin\/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data","volume":"35","author":"Joussen","year":"2021","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.isci.2025.112625_bib40","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.ophtha.2024.02.014","article-title":"TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2","volume":"131","author":"Khanani","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.isci.2025.112625_bib41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(22)00018-6","article-title":"Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials","volume":"399","author":"Wykoff","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2025.112625_bib42","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027986","article-title":"Pentose Pathway Activation Is Superior to Increased Glycolysis for Therapeutic Angiogenesis in Peripheral Arterial Disease","volume":"12","author":"Zaied","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.isci.2025.112625_bib43","first-page":"48","article-title":"Inhibition of VEGFR2 Activation and Its Downstream Signaling to ERK1\/2 and Calcium by Thrombospondin-1 (TSP1): In silico Investigation","volume":"8","author":"Bazzazi","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.isci.2025.112625_bib44","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3389\/fphys.2018.00644","article-title":"Computer Simulation of TSP1 Inhibition of VEGF-Akt-eNOS: An Angiogenesis Triple Threat","volume":"9","author":"Bazzazi","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.isci.2025.112625_bib45","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jtbi.2018.06.029","article-title":"Computational modeling of synergistic interaction between alphaVbeta3 integrin and VEGFR2 in endothelial cells: Implications for the mechanism of action of angiogenesis-modulating integrin-binding peptides","volume":"455","author":"Bazzazi","year":"2018","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.isci.2025.112625_bib46","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.isci.2019.10.006","article-title":"Angiopoietin-Tie Signaling Pathway in Endothelial Cells: A Computational Model","volume":"20","author":"Zhang","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.isci.2025.112625_bib47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41540-021-00194-6","article-title":"A systems biology model of junctional localization and downstream signaling of the Ang-Tie signaling pathway","volume":"7","author":"Zhang","year":"2021","journal-title":"NPJ Syst. Biol. Appl."},{"key":"10.1016\/j.isci.2025.112625_bib48","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1021\/acsptsci.3c00008","article-title":"Combining Multikinase Tyrosine Kinase Inhibitors Targeting the Vascular Endothelial Growth Factor and Cluster of Differentiation 47 Signaling Pathways Is Predicted to Increase the Efficacy of Antiangiogenic Combination Therapies","volume":"6","author":"Zhang","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.isci.2025.112625_bib49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0854.2009.01001.x","article-title":"Ligand-stimulated VEGFR2 signaling is regulated by co-ordinated trafficking and proteolysis","volume":"11","author":"Bruns","year":"2010","journal-title":"Traffic"},{"key":"10.1016\/j.isci.2025.112625_bib50","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1182\/blood-2011-01-328773","article-title":"Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output","volume":"118","author":"Ballmer-Hofer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.isci.2025.112625_bib51","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1600-0854.2006.00462.x","article-title":"Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells","volume":"7","author":"Ewan","year":"2006","journal-title":"Traffic"},{"key":"10.1016\/j.isci.2025.112625_bib52","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/MCB.01374-08","article-title":"New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival","volume":"29","author":"Chabot","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.isci.2025.112625_bib53","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1161\/CIRCRESAHA.111.243352","article-title":"Orai1 and CRAC channel dependence of VEGF-activated Ca2+ entry and endothelial tube formation","volume":"108","author":"Li","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.isci.2025.112625_bib54","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1242\/jcs.03077","article-title":"Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization","volume":"119","author":"Bogdanovic","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.isci.2025.112625_bib55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jacc.2008.02.045","article-title":"Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease","volume":"52","author":"Findley","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.isci.2025.112625_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2018.02.003","article-title":"Circulating angiopoietin-2 and its soluble receptor Tie-2 concentrations are related to inflammatory markers in the general population","volume":"105","author":"Schuldt","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.isci.2025.112625_bib57","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/ncb1486","article-title":"VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin","volume":"8","author":"Gavard","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.isci.2025.112625_bib58","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S1097-2765(00)80221-X","article-title":"Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability","volume":"4","author":"Eliceiri","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2025.112625_bib59","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1073\/pnas.1525349113","article-title":"Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages","volume":"113","author":"Peterson","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112625_bib60","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/01.MP.0000071841.17900.69","article-title":"Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?","volume":"16","author":"Moon","year":"2003","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.isci.2025.112625_bib61","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910362","article-title":"Anti-VEGF-A\/ANG2 combotherapy limits pathological angiogenesis in the eye: a replication study","volume":"11","author":"Wolf","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.isci.2025.112625_bib62","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1038\/srep08856","article-title":"Src inhibitor reduces permeability without disturbing vascularization and prevents bone destruction in steroid-associated osteonecrotic lesions in rabbits","volume":"5","author":"He","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.112625_bib63","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.54056","article-title":"Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin","volume":"9","author":"Smith","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.isci.2025.112625_bib64","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4161\/cc.5.5.2538","article-title":"Akt1 in endothelial cell and angiogenesis","volume":"5","author":"Somanath","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.isci.2025.112625_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.998475","article-title":"ERK signaling for cell migration and invasion","volume":"9","author":"Samson","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.isci.2025.112625_bib66","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/cam.29026","article-title":"Endothelial permeability and VE-cadherin: a wacky comradeship","volume":"8","author":"Gavard","year":"2014","journal-title":"Cell Adhes. Migrat."},{"key":"10.1016\/j.isci.2025.112625_bib67","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708253","article-title":"Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer","volume":"13","author":"Khan","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.isci.2025.112625_bib68","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrd.2016.278","article-title":"Therapeutic targeting of the angiopoietin-TIE pathway","volume":"16","author":"Saharinen","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2025.112625_bib69","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1073\/pnas.0307574101","article-title":"COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity","volume":"101","author":"Cho","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112625_bib70","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ccell.2016.10.018","article-title":"Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment","volume":"30","author":"Park","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2025.112625_bib71","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1055\/s-0038-1636543","article-title":"Angiopoietin-2 and Survival in Peripheral Artery Disease Patients","volume":"118","author":"Hobaus","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.isci.2025.112625_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10456-009-9160-6","article-title":"Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?","volume":"13","author":"Gotink","year":"2010","journal-title":"Angiogenesis"},{"key":"10.1016\/j.isci.2025.112625_bib73","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nrd2380","article-title":"Molecular basis for sunitinib efficacy and future clinical development","volume":"6","author":"Faivre","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2025.112625_bib74","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdm223","article-title":"Dasatinib: a new step in molecular target therapy","volume":"18","author":"Olivieri","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.isci.2025.112625_bib75","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1097-2765(05)00089-4","article-title":"Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine","volume":"6","author":"Walker","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2025.112625_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061489","article-title":"c-Src and EGFR Inhibition in Molecular Cancer Therapy: What Else Can We Improve?","volume":"12","author":"Belli","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.isci.2025.112625_bib77","doi-asserted-by":"crossref","first-page":"801","DOI":"10.7150\/thno.4419","article-title":"Therapeutic angiogenesis for treating cardiovascular diseases","volume":"2","author":"Deveza","year":"2012","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2025.112625_bib78","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41540-023-00308-2","article-title":"Experiment-based computational model predicts that IL-6 classic and trans-signaling exhibit similar potency in inducing downstream signaling in endothelial cells","volume":"9","author":"Song","year":"2023","journal-title":"NPJ Syst. Biol. Appl."},{"key":"10.1016\/j.isci.2025.112625_bib79","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12964-020-00595-w","article-title":"ERK and Akt exhibit distinct signaling responses following stimulation by pro-angiogenic factors","volume":"18","author":"Song","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.isci.2025.112625_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1351753","article-title":"Endothelial cells signaling and patterning under hypoxia: a mechanistic integrative computational model including the Notch-Dll4 pathway","volume":"15","author":"Oliveira","year":"2024","journal-title":"Front. Physiol."},{"key":"10.1016\/j.isci.2025.112625_bib81","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/ATVBAHA.110.219550","article-title":"Phase I\/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia","volume":"31","author":"Morishita","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.isci.2025.112625_bib82","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jacbts.2021.10.014","article-title":"Dynamic Multiscale Regulation of Perfusion Recovery in Experimental Peripheral Arterial Disease: A Mechanistic Computational Model","volume":"7","author":"Zhao","year":"2022","journal-title":"JACC. Basic Transl. Sci."},{"key":"10.1016\/j.isci.2025.112625_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102112","article-title":"A data-driven computational model enables integrative and mechanistic characterization of dynamic macrophage polarization","volume":"24","author":"Zhao","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.isci.2025.112625_bib84","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj8540","article-title":"Flow in fetoplacental-like microvessels in vitro enhances perfusion, barrier function, and matrix stability","volume":"9","author":"Cherubini","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2025.112625_bib85","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41596-019-0144-8","article-title":"Microfabricated blood vessels for modeling the vascular transport barrier","volume":"14","author":"Polacheck","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.isci.2025.112625_bib86","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1093\/bioinformatics\/btw469","article-title":"BioNetGen 2.2: advances in rule-based modeling","volume":"32","author":"Harris","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2025.112625_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1145\/3539801","article-title":"Enabling New Flexibility in the SUNDIALS Suite of Nonlinear and Differential\/Algebraic Equation Solvers","volume":"48","author":"Gardner","year":"2022","journal-title":"ACM Trans. Math Software"},{"key":"10.1016\/j.isci.2025.112625_bib88","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1137\/0728030","article-title":"A Globally Convergent Augmented Lagrangian Algorithm for Optimization with General Constraints and Simple Bounds","volume":"28","author":"Conn","year":"1991","journal-title":"SIAM J. Numer. Anal."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225008867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225008867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:14:46Z","timestamp":1768965286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225008867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2589004225008867"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.112625","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promoting vascular stability through Src inhibition and Tie2 activation: A model-based analysis","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.112625","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112625"}}